The British Menopause Society Council aims to aid health professionals to inform and advise women about postreproductive health. This guidance refers to the long-term condition of urogenital atrophy. Treatment choice should be based on up to date information and targeted to individual women's needs. Non-estrogen and estrogen-based treatments are discussed.
MichelJP, NewtonJL, KirkwoodTB. Medical challenges of improving the quality of a longer life. JAMA2008;299:688–90
2.
WillhiteLA, O' ConnellMB. Urogenital atrophy: prevention and treatment. Pharmacotherapy2001;21:464–80
3.
van GeelenJM, van de WeijerPH, ArnoldsHT. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50–75 years. Int Urogynecol J Pelvic Floor Dysfunct2000;11:9–14
4.
OskayUY, BejiNK, YalcinO. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand2005;84:72–8
5.
American College of Obstetricians and Gynecologists Women's Health Care Physicians. Genitourinary tract changes. Obstet Gynecol2004;104:56S–61S
6.
BygdemanM, SwahnML. Replens versus dienoestriol cream in the symptomatic treatment of vaginal atrophy in post menopausal women. Maturitas1996;23:259–63
7.
RosenAD, RosenT. Study of condom integrity after brief exposure to over-the-counter vaginal preparations. South Med J1999;92:305–7
8.
Castelo-BrancoC, CanceloMJ, VilleroJ, NohalesF, JuliaMD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas2005;52:S46–52
9.
SimunicV, BanovicI, CiglarS, Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet2003;82:187–97
10.
SucklingJ, LethabyA, KennedyR. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev2006;4:CD001500
BachmannG, LoboRA, GutR, NachtigallL, NotelovitzM. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol2008;111:67–76
13.
RiouxJE, DevlinC, GelfandMM, SteinbergWM, HepburnDS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause2000;7:156–61
14.
CKS. Clinical Topic. Menopause. See [http://www.cks.library.nhs.uk/menopause] (last accessed 27 May 2008)
15.
NotelovitzM, FunkS, NanavatiN, MazzeoM. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol2002;99:556–62
16.
SantenRJ, PinkertonJV, ConawayM, RopkaM, WisniewskiL, DemersL, KleinKO. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause2002;9:179–87
17.
WeisbergE, AytonR, DarlingG, FarrellE, MurkiesA, O'NeillS, KirkegardY, FraserIS. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric2005;8:83–92
18.
WaasethM, BakkenK, DumeauxV, OlsenKS, RylanderC, FigenschauY, LundE. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort – a cross-sectional analysis. BMC Womens Health2008;8:1
19.
ReesM, PurdieDW. Management of the Menopause. The Handbook 2006. London, UK: RSM Press, 2006
20.
WeiderpassE, BaronJA, AdamiHO, Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet1999;353:1824–8
21.
CardozoL, BachmannG, McClishD, FondaD, BirgersonL. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol1998;92:722–7
22.
PerrottaC, AznarM, MejiaR, AlbertX, NgCW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev2008;2:CD005131
23.
FantlJA, CardozoL, McClishDK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol1994;83:12–8
24.
WrightTCJr, CoxJT, MassadLS, TwiggsLB, WilkinsonEJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA2002;287:2120–9
25.
WrightTCJr, MassadLS, DuntonCJ, SpitzerM, WilkinsonEJ, SolomonD; for the 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis2007;11:201–22
